About this trial
The pAIn-sense study aims to revolutionize the monitoring and treatment of chronic pain, a major health concern that significantly impacts psychological well-being and quality of life. Traditional approaches to pain management face challenges like unspecific drug use and high healthcare costs, and they often leave patients dissatisfied. PAIn-sense aims at comprehensively understanding pain from both physical and emotional perspectives. To accomplish this, the study will employ advanced Artificial Intelligence (AI) techniques and wearable sensing technology. The study aims to monitor patients continuously, during both day and night activities, to gather a multidimensional set of data on their physiological, psychosocial, and pain conditions.
Eligibility criteria
Qualifiers
Ongoing nociceptive pain after an injury or Neuropathic pain (acute or chronic)
Familiar with using electronic devices
Disqualifiers
Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
Unable or not willing to give informed consent
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
Sponsors and collaborators
ETH Zurich
Lead sponsor
Balgrist University Hospital
Collaborator